NCT05035836 A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) Status RECRUITING Phase PHASE2
NCT04987632 Effect of Acupuncture Plus Governor Vessel Moxibustion Combined With Letrozole on Live Birth in Anovulatory Infertile Women With Spleen-kidney Yang Deficiency PCOS Status UNKNOWN Phase PHASE1
NCT04985266 A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer Status RECRUITING Phase PHASE2
NCT04964934 Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04942899 Letrozole Plus Metronomic Capecitabine as First-line Treatment for Patients With Recurrent or Metastatic Breast Cancer Status UNKNOWN Phase PHASE2
NCT04931342 A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04872608 A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer Status WITHDRAWN Phase PHASE1
NCT04856371 Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer Status UNKNOWN Phase PHASE1
NCT04852081 Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study. Status UNKNOWN Phase N/A
NCT04666805 Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast Status UNKNOWN Phase N/A
NCT04630210 Investigating Atezolizumab in Newly Diagnosed ER Positive Breast Cancer Patients According to Their AdipOsity Status WITHDRAWN Phase EARLY_PHASE1
NCT04614194 Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib Status RECRUITING Phase PHASE2
NCT04606446 Study of PF-07248144 in Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE2
NCT04603183 ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL Status COMPLETED Phase PHASE2
NCT04590482 Letrozole Pretreatment With Misoprostol Induction of Abortion in First Trimester Missed Abortion Status UNKNOWN Phase PHASE4
NCT04551495 Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04546009 A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04486352 A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT04478266 Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer Status TERMINATED Phase PHASE3